Home > Financial Ratios > GLAND PHARMA
AD     Remove this Ad

GLAND PHARMA Last 5 Year Working Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Working Capital/Sales(x) 1.081.330.590.840.75

What is the latest Working Capital/Sales ratio of GLAND PHARMA ?

The latest Working Capital/Sales ratio of GLAND PHARMA is 1.08 based on Mar2025 Consolidated results.
Year Working Capital/Sales
Mar20251.08
Mar20241.33
Mar20230.59
Mar20220.84
Mar20210.75

How is Working Capital/Sales of GLAND PHARMA Trending?

Years Working Capital/Sales % Change
Mar2025 1.08
-18.80
Mar2024 1.33
125.42
Mar2023 0.59
-29.76
Mar2022 0.84
12.00
Mar2021 0.75 -

Other Financial Ratios of GLAND PHARMA


Compare Working Capital/Sales ratio of peers of GLAND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLAND PHARMA ₹29,685.4 Cr -2.5% 7.5% 22.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹415,217.0 Cr 0.4% 5.6% 1.8% Stock Analytics
DIVIS LABORATORIES ₹166,047.0 Cr -0.5% 3.3% 7.9% Stock Analytics
TORRENT PHARMACEUTICALS ₹148,872.0 Cr 4.5% 10% 41.5% Stock Analytics
DR REDDYS LABORATORIES ₹108,454.0 Cr 1.5% 4.8% 9.1% Stock Analytics
CIPLA ₹107,136.0 Cr -1.7% 1% -10.5% Stock Analytics


GLAND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLAND PHARMA

-2.5%

7.5%

22.1%

SENSEX

-1.5%

0.8%

8.2%


You may also like the below Video Courses